000 01139 a2200325 4500
005 20250516034846.0
264 0 _c20111003
008 201110s 0 0 eng d
022 _a1875-9777
024 7 _a10.1016/j.stem.2011.04.009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSolbakk, Jan Helge
245 0 0 _aThe tragedy of translation: the case of "first use" in human embryonic stem cell research.
_h[electronic resource]
260 _bCell stem cell
_cMay 2011
300 _a479-81 p.
_bdigital
500 _aPublication Type: Comment; Journal Article
650 0 4 _aBiomedical Research
_xethics
650 0 4 _aBiotechnology
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aCost-Benefit Analysis
650 0 4 _aHumans
650 0 4 _aPatient Selection
_xethics
650 0 4 _aRisk Adjustment
650 0 4 _aSpinal Cord Injuries
_xeconomics
650 0 4 _aStem Cell Research
650 0 4 _aStem Cell Transplantation
700 1 _aZoloth, Laurie
773 0 _tCell stem cell
_gvol. 8
_gno. 5
_gp. 479-81
856 4 0 _uhttps://doi.org/10.1016/j.stem.2011.04.009
_zAvailable from publisher's website
999 _c20812888
_d20812888